Evofem Biosciences/ US30048L2034 /
8/10/2022 9:59:39 PM | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
0.48USD | - | 88,973 Turnover: 43,978.80 |
-Bid Size: - | -Ask Size: - | 0.58 | 0.41 |
GlobeNewswire
12/18/2023
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Eagle Bulk ...
GlobeNewswire
12/14/2023
ALERT: The M&A Class Action Firm Continues Investigating the Merger – EAR, IMGN, CVLY, EVFM
GlobeNewswire
12/12/2023
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Eagle Bulk ...
Newsfile Corp
8/1/2022
Evofem Biosciences Discusses Innovative Woman-Controlled Contraceptive with The Stock Day Podcast
GlobeNewswire
3/28/2022
Saundra Pelletier, CEO of Evofem Biosciences, to Receive Honorary Degree from Husson University
GlobeNewswire
3/19/2020
TRACON Pharmaceuticals Announces Appointment of Saundra Pelletier to Board of Directors
GlobeNewswire
4/16/2019
STOCKHOLDER ALERT: Kaskela Law LLC Announces Investigation of Evofem Biosciences, Inc. – EVFM
GlobeNewswire
6/6/2018
Daré Bioscience, Inc. Expands Leadership Team, Appointing David Friend, Ph.D. to Chief Scientific Of...
GlobeNewswire
6/4/2018
Daré Bioscience, Inc. Expands Leadership Team, Appointing Mary Jarosz, RPh, to Global Head of Regula...
GlobeNewswire
1/5/2018
Neothetics Announces Adjournment of Special Stockholders Meeting to Solicit Additional Votes for Mer...
GlobeNewswire
11/8/2017
Neothetics Provides Business Update and Reports Third Quarter 2017 Financial Results